Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients.

This study suggests that a DD strategy is likely to be cost-saving versus empirical treatment for immunocompromised patients with persistent or recurrent neutropenic fevers. PMID: 25891805 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25891805?dopt=Abstract

Source: Clinical Therapeutics - April 16, 2015 Category: Drugs & Pharmacology Authors: Barnes R, Earnshaw S, Herbrecht R, Morrissey O, Slavin M, Bow E, McDade C, Charbonneau C, Weinstein D, Kantecki M, Schlamm H, Maertens J Tags: Clin Ther Source Type: research